Treatment of major depression in general practice: A double-blind comparison of paroxetine and lofepramine

British Journal of Clinical Practice

Volumn 50, Issue 5, 1996, Pages 240-244

  Moon, Cal ^a,b   Vince, Cornwall M ^b  

^a Health Centre   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LOFEPRAMINE; PAROXETINE;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENERAL PRACTICE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIRED ASSOCIATE LEARNING; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; COGNITION; DEPRESSION; DOUBLE-BLIND METHOD; FAMILY PRACTICE; HUMANS; LOFEPRAMINE; MIDDLE AGED; PAROXETINE;

EID: 0029793955     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Thomas DR, Nelson DR, Johnson AM. Biochemical effect of the antidepressant paroxetine, a specific 5-HT (hydroxytryptamine) uptake inhibitor. Pstchnpharmacology 1987:93: 193-200.
2. Marsden CA. Changes in human whole blood 5-HT and platelet 5-HT during treatment with paroxetine, a selective 5-HT uptake inhibitor. J Psvchopharmacol 1987; 1: 244-250.
3. Raptopoulus P, McClelland OR, Jackson D. The clinical pharmacology of paroxetine in healthy subjects. Ada Psychiatr Scand 1989; 80(suppl 350): 46-48.
4. McClelland GR, Raptopoulus P. EEG and blood levels of the potential antidepressant paroxetine after a single oral dose to normal volunteers. Psvchopharmacology- 1984; 83: 327-329.
5. McClelland GR, Raptopoulus P, Jackson D. The effect of paroxetine on the quantitative EEG. Acta Psychiatr Scand 1989; 80(suppl 350): 50-52.
6. Laursen AL, Mikkelsen PL, Rasmussen S et al. Paroxetine in the treatment of depression - a randomized comparison with amitriptyline. Acta Psychiatr Scand 1985; 71: 249-255.
7. Bascara L. A double blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients. Ac ta Psychiatr Scand 1989; 80: 141-142.
8. Guillibert E, Pelicier Y, Archambault JP et al. A double blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatr Scand 1989; 80: 132-134.
9. Dunbar GC, Cohn JB, Fabre LF et al. A comparison of paroxetine, imipramine and placebo in depressed out-patients. Br J Psychiatr 1991; 159: 394-398.
10. Hindmarch I, Harrison C. The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving. Hum Psychopharmacol 1988; 3: 13-20.
11. Deijen JB, Loriaux SM, Orlebeke JF et al. Effects of paroxetine and maprotiline on mood, perceptual motor skills, and eye movements in healthy volunteers. J Psychopharmacol 1989; 3: 149-155.
12. Robbe HWJ, Schoenmakers EAMJ, O'Hanlon JF. Acute and subchronic effects of paroxetine and amitriptyline on psychomotor and driving performance. Presented at the 8th World Congress of Psychiatry, Athens, 1989.
13. Lancaster SG, Gonzalez JP. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1989; 37: 123-140.
14. Bemik V, Maia E. Therapeutical and clinical evaluation of a new antidepressant drug, lofepramine (EMD 30182), in comparison to amitriptyline in the treatment of depression. Rev Bras Clin Ter 1978; 7: 43-50.
15. Feighner JP, Meredith CH, Dutt JE et al. A double blind comparison of lofepramine, imipramine and placebo in patients with primary depression. Ada Psychiatr Scand 1982, 66: 100-108.
16. d'Elia G, Borg S, Hermann L et al. Comparative clinical evaluation of lofepramine and imipramine: psychiatric aspects. Acta Psychiatr Scand 1977; 55: 10-20.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd Edn revised. Washington DC: American Psychiatric Association, 1987.
18. Montgomery SA, Asberg M. A new depression rating scale designed to be sensitive to change. Br J Psychiatr 1979; 134: 182-189.
19. Inglis J. A paired-associate learning test for use in elderly psychiatric patients. J Ment Sei 1969; 109: 368-370.
20. Dixon RA, Thornton JA. Tests of recovery from anaesthesia and sedation: intravenous diazepam in dentistry. Br J Anaesth 1973; 45: 207-215.
21. Hutchinson DR. A double blind comparison ofparoxetine and amitriptyline in ejderly depressed community patients. Presented at the 17th CINP Congress, Kyoto, 1990.
22. Shillingford JS, Hindmarch I, Clark A et al. A double blind comparison of 'Seroxat' and dothiepin on efficacy and tolerability in depressed community patients. Presented at the 17th CINP Congress, Kyoto, 1990.
23. de Wilde J, Mertens C, Bartholome P. A double blind, comparative, multicentre study comparing paroxetine and fluoxeline in depressed patients. Presented at the 5th World Congress of Biological Psychiatry. Florence, 1991.